91 related articles for article (PubMed ID: 34446451)
1. Biodistribution of
Iqbal R; Yaqub M; Oprea-Lager DE; Liu Y; Luik AM; Beelen AP; Schuit RC; Windhorst AD; Boellaard R; Menke-van der Houven van Oordt CW
J Nucl Med; 2022 May; 63(5):694-699. PubMed ID: 34446451
[TBL] [Abstract][Full Text] [Related]
2. Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[
Mankoff D; Balogová S; Dunnwald L; Dehdashti F; DeVries E; Evangelista L; Van Kruchten M; Vaz SC; Fowler A; Linden H; Ulaner GA
J Nucl Med; 2024 Feb; 65(2):221-223. PubMed ID: 38071554
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with
Gennari A; Brain E; De Censi A; Nanni O; Wuerstlein R; Frassoldati A; Cortes J; Rossi V; Palleschi M; Alberini JL; Matteucci F; Piccardo A; Sacchetti G; Ilhan H; D'Avanzo F; Ruffilli B; Nardin S; Monti M; Puntoni M; Fontana V; Boni L; Harbeck N;
Ann Oncol; 2024 Jun; 35(6):549-558. PubMed ID: 38423389
[TBL] [Abstract][Full Text] [Related]
4. Dynamic whole-body [
Pedersen MA; Munk OL; Dias AH; Steffensen JH; Møller AL; Johnsson AL; Hansen KV; Bender D; Jakobsen S; Busk M; Gormsen LC; Tramm T; Borgquist S; Vendelbo MH
EJNMMI Res; 2024 Mar; 14(1):24. PubMed ID: 38436824
[TBL] [Abstract][Full Text] [Related]
5. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[
Katzenellenbogen JA
Nucl Med Biol; 2021 Jan; 92():24-37. PubMed ID: 32229068
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Analysis of [
Ghazanfari N; Doorduin J; van der Weijden CWJ; Willemsen ATM; Glaudemans AWJM; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2024 Apr; 26(2):351-359. PubMed ID: 38263484
[TBL] [Abstract][Full Text] [Related]
7. Diffuse bilateral
Phillips EF; Karak PK
J Med Imaging Radiat Sci; 2023 Dec; 54(4):726-731. PubMed ID: 37620179
[TBL] [Abstract][Full Text] [Related]
8. Utility of
Lin FI; Gonzalez EM; Kummar S; Do K; Shih J; Adler S; Kurdziel KA; Ton A; Turkbey B; Jacobs PM; Bhattacharyya S; Chen AP; Collins JM; Doroshow JH; Choyke PL; Lindenberg ML
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):500-508. PubMed ID: 27872957
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.
van Kruchten M; Glaudemans AWJM; de Vries EFJ; Schröder CP; de Vries EGE; Hospers GAP
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1674-1681. PubMed ID: 26091705
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
Munter-Young R; Fuentes-Alburo A; DiGregorio N; Neeser K; Gultyaev D
PLoS One; 2024; 19(5):e0302486. PubMed ID: 38743917
[TBL] [Abstract][Full Text] [Related]
11. Uterine Uptake of Estrogen and Progestogen-Based Radiotracers in Rhesus Macaques with Endometriosis.
Wilson RC; Link JM; Lee YZ; Oldan JD; Young SL; Slayden OD
Mol Imaging Biol; 2024 Apr; 26(2):334-343. PubMed ID: 38133866
[TBL] [Abstract][Full Text] [Related]
12. A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).
Peterson LM; Kurland BF; Schubert EK; Link JM; Gadi VK; Specht JM; Eary JF; Porter P; Shankar LK; Mankoff DA; Linden HM
Mol Imaging Biol; 2014 Jun; 16(3):431-40. PubMed ID: 24170452
[TBL] [Abstract][Full Text] [Related]
13.
Grabher BJ
J Nucl Med Technol; 2023 Sep; 51(3):188-193. PubMed ID: 37433673
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison of
Kiatkittikul P; Mayurasakorn S; Promteangtrong C; Kunawudhi A; Siripongsatian D; Hirata N; Jantarato A; Boonkawin N; Yaset S; Kongsakorn P; Phewnual W; Chotipanich C
Eur J Hybrid Imaging; 2023 Dec; 7(1):23. PubMed ID: 38105347
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-AJR Expert Panel Narrative Review.
Covington MF; O'Brien SR; Lawhn-Heath C; Pantel AR; Ulaner GA; Linden HM; Dehdashti F
AJR Am J Roentgenol; 2023 Dec; ():. PubMed ID: 38117098
[TBL] [Abstract][Full Text] [Related]
16. First-in-human evaluation of [
Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
[TBL] [Abstract][Full Text] [Related]
17. ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors.
You S; Xie Y; Ji M; Liu C; Zhao Y; Gong C; Hu S; Li Y; Yang Z; Wang B
Ther Adv Med Oncol; 2023; 15():17588359231216093. PubMed ID: 38107829
[TBL] [Abstract][Full Text] [Related]
18. An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.
Chandarlapaty S; Dickler MN; Perez Fidalgo JA; Villanueva-Vázquez R; Giltnane J; Gates M; Chang CW; Cheeti S; Fredrickson J; Wang X; Collier A; Moore HM; Metcalfe C; Lauchle J; Humke EW; Bardia A
Clin Cancer Res; 2023 Aug; 29(15):2781-2790. PubMed ID: 37261814
[TBL] [Abstract][Full Text] [Related]
19. Uterine uptake of estrogen and progestogen-based radiotracers in rhesus macaques with endometriosis.
Wilson RC; Link JM; Lee YZ; Oldan JD; Young SL; Slayden OD
Res Sq; 2023 Sep; ():. PubMed ID: 37720028
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Clinical-Grade [(18)F]-Fluoroestradiol as a Surrogate PET Biomarker for the Evaluation of Estrogen Receptor-Targeting Therapeutic Drug.
Dixit M; Shi J; Wei L; Afari G; Bhattacharyya S
Int J Mol Imaging; 2013; 2013():278607. PubMed ID: 23762549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]